Cohort Study for Gastric MALT Lymphoma
ConditionGastric MALT Lymphoma
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-75
SponsorSeoul National University Hospital
About this trial
The goal of this observational study is to establish clinical data and tissue repository in patients with gastric MALT lymphoma and controls.
Participants will be asked to provide clinical information and various tissues (saliva, gastric mucosa, and feces).
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Newly diagnosed as gastric MALT lymphoma [Control group]
Patients who underwent
diagnosed upper endoscopy for dyspepsia and had chronic gastritis,
therapeutic upper endoscopy for gastric hyperplastic polyps, or
Disqualifiers
History of gastric or other malignancy
Use of antibiotics or probiotics within 4 weeks
Uncontrolled chronic illnesses
Trial population
Eligible patients who visited participating hospital will be asked, and upon providing informed consent, will be enrolled in the study.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
MALT lymphoma
Other interventionNew diagnosis with gastric MALT lymphoma
Treatment groups
300 Participants
are divided into 2 treatment groupsGroup A: MALT lymphoma1 intervention
Group B: Control group0 interventions
Trial outcomes
Primary outcomes
1
Remission of gastric MALT lymphoma
Remission of gastric MALT lymphoma
Time frame
Within 3 years from diagnosisSecondary outcomes
1
Eradication of H. pylori infection
Eradication of H. pylori infection
Time frame
Within 6 month from eradication therapySponsors and contacts
Click on the lead sponsor to view all of their trials.
Seoul National University Hospital
Lead sponsor
Kangbuk Samsung Hospital
Collaborator
Korea University Ansan Hospital
Collaborator
Source ClinicalTrials.gov